Cardinal Health Inc. CAH, +2.28% announced on Thursday that it has authorized a $3.5 billion stock-buyback program through the end of 2027. According to FactSet, Cardinal Health expects a 2024 adjusted profit between $6.45 and $6.70 per share. This compares to Wall Street analysts’ estimates of $6.55 per share. The company has also lowered its adjusted profit forecast for 2023 to $5.65-$5.80 per share from the previous range of $5.60-5.80, which was compared with analyst expectations of $5.73. Cardinal Health has raised its financial goal for its pharmaceutical division to 4%-6% growth from its previous projection of low-single-digit to midsingle-digit growth. Cardinal Health’s stock has risen 8.3% by 2023, while the S&P500 SPX is up 11.2%.